微创血肿及脑室穿刺体外引流治疗丘脑出血的临床研究

目的：探讨血肿穿刺加脑室外引流治疗丘脑出血伴破入脑室的疗效。方法：笔者对所在医院2011年10月-2014年1月收治的43例丘脑出血患者采用微创软通道血肿及脑室穿刺体外引流治疗方法和疗效进行回顾性分析。根据日常生活活动能力量表（Barthel指数）的评价标准对术后疗效进行评估。结果：95%的患者在5 d内血肿基本消失,术后6月恢复良好34例（79.1%）,重度功能障碍与生活依赖明显7例（9.6%）,生活完全依赖2例（4.7%）。结论：丘脑出血破入脑室,采用血肿及脑室穿刺体外引流术加尿激酶液化血肿的治疗方法,安全有效,可改善其预后,恢复快。

Clinical Studies of Hematoma Minimally Invasive in Vitro Ventricle Puncture Drainage Treatment for Patients with Thalamic Hemorrhage

Objective：To explore the curative effect of hematoma puncture and intraventricular external drainage method for the treatment of thalamic hemorrhage. Method：Minimally invasive hematoma and soft channel ventricle puncture drainage were used to treat 43 cases of thalamic hemorrhage between October 2011 and January 2014.The postoperative curative effect were evaluateted according to the daily life activities ability scale（Barthel index） of evaluation standard.Result：Hematoma disappeared in 95% of all the patients within 5 d, 34 cases（79.1%） of patients were in good recovery after 6 months of the operation.7 cases（9.6%）of patients were in severed dysfunction.Life dependent entirely on care were seen in only 2 cases（4.7%）. Conclusion：Hematoma and intraventricular hematoma puncture drainage with urokinase in vitro liquefaction treatment is safe and effective,it can improve prognosis, and accelerate the recovery progress.